Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pandemic Influenza”

240 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 240 results

Testing effectiveness (Phase 2)Study completedNCT01640691
What this trial is testing

Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults

Who this might be right for
Pandemic Influenza
Adimmune Corporation 39
Early research (Phase 1)Study completedNCT00664417
What this trial is testing

Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine

Who this might be right for
InfluenzaOrthomyxoviridae Infections
Sanofi 375
Not applicableStudy completedNCT01100294
What this trial is testing

Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children

Who this might be right for
Influenza
Fluart Innovative Vaccine Ltd, Hungary 10
Early research (Phase 1)Study completedNCT00973895
What this trial is testing

VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old

Who this might be right for
Influenza A Virus, H1N1 SubtypeNovel Swine-Origin
National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Study completedNCT00306995
What this trial is testing

Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population

Who this might be right for
InfluenzaInfluenza Vaccines
GlaxoSmithKline 385
Early research (Phase 1)UnknownNCT06046092
What this trial is testing

H7HLAII DNA Influenza Vaccine

Who this might be right for
Influenza APandemic Influenza
Oslo University Hospital 27
Testing effectiveness (Phase 2)Study completedNCT00952419
What this trial is testing

Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 Years

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 474
Early research (Phase 1)Looking for participantsNCT06355232
What this trial is testing

Covid-19 and Influenza Oral Vaccine Study

Who this might be right for
covid19 InfectionInfluenza, Human
Vaxine Pty Ltd 100
Large-scale testing (Phase 3)Study completedNCT00970177
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 812
Testing effectiveness (Phase 2)Study completedNCT00742885
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine

Who this might be right for
Influenza
GlaxoSmithKline 100
Testing effectiveness (Phase 2)Study completedNCT00545701
What this trial is testing

Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults

Who this might be right for
InfluenzaOrthomyxoviridae Infections
Sanofi Pasteur, a Sanofi Company 100
Early research (Phase 1)Study completedNCT00347672
What this trial is testing

Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 42
Testing effectiveness (Phase 2)Study completedNCT06602531
What this trial is testing

Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults

Who this might be right for
Influenza, Human
Arcturus Therapeutics, Inc. 212
Testing effectiveness (Phase 2)Study completedNCT00900991
What this trial is testing

Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd
Testing effectiveness (Phase 2)UnknownNCT01055990
What this trial is testing

Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients

Who this might be right for
Virus DiseasesRespiratory Tract DiseasesRespiratory Tract Infections+2 more
Shanghai Public Health Clinical Center 7
Early research (Phase 1)Looking for participantsNCT07111078
What this trial is testing

Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

Who this might be right for
Influenza PreventionPandemic Influenza Prevention
National Institute of Allergy and Infectious Diseases (NIAID) 56
Not applicableStudy completedNCT01289418
What this trial is testing

Surveillance for Adverse Events Following Pandemic H1N1 Immunization

Who this might be right for
Novel Influenza A/H1N1
PHAC/CIHR Influenza Research Network 6,525
Early research (Phase 1)Study completedNCT00694213
What this trial is testing

Pandemic Influenza Plasmid DNA Vaccines (Needle-Free)

Who this might be right for
Influenza
Vical 47
Early research (Phase 1)Looking for participantsNCT07305207
What this trial is testing

Establishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic Preparedness

Who this might be right for
Influenza (Healthy Volunteers)
Dalhousie University 32
Early research (Phase 1)Study completedNCT00755703
What this trial is testing

Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.

Who this might be right for
Influenza A Subtype H5N1 Infection
Altimmune, Inc. 48
Next Page